Page 1 | Search Results | Blood Advances | American Society of Hematology

1-20 of 3917

Sort by

Sort Order Select

Journal Articles

Hertz L, Flormann D, Birnbaumer L, et al. Evidence of in vivo exogen protein uptake by red blood cells: a putative therapeutic concept. Blood Adv . 2023;7(6):1033-1039.

Blood Adv (2023) 7 (18): 5315.

https://doi.org/10.1182/bloodadvances.2023011151

Published: 2023

Journal Articles

A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy

Ariel Kleman, Arun Singavi, Lauren Pommert, Angela J. Mathison, Parameswaran Hari, Binod Dhakal, Meera Mohan, Siegfried Janz, Jennifer M. Knight, Mithun V. Shah, Carolina Schinke, Robert Burns, George Francis Steinhardt, Sridhar Rao, Karen Carlson

Blood Adv (2023) 7 (18): 5549–5553.

https://doi.org/10.1182/bloodadvances.2022008953

Published: 2023

Includes: Supplemental data

Journal Articles

Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients

Blood Adv (2023) 7 (18): 5446–5457.

https://doi.org/10.1182/bloodadvances.2022009274

Published: 2023

Includes: Supplemental data

Journal Articles

Intrinsic tumor resistance to CAR T cells is a dynamic transcriptional state that is exploitable with low-dose radiation

Alexander B. Kim, Ssu-Yu Chou, Solomon Kang, Eric Kwon, Matthew Inkman, Jeff Szymanski, Neal Andruska, Cian Colgan, Jin Zhang, Joanna C. Yang, Nathan Singh, Carl J. DeSelm

Blood Adv (2023) 7 (18): 5396–5408.

https://doi.org/10.1182/bloodadvances.2022009543

Published: 2023

Includes: Supplemental data

Journal Articles

Mecom mutation related to radioulnar synostosis with amegakaryocytic thrombocytopenia reduces HSPCs in mice

Koki Nagai, Tetsuya Niihori, Akihiko Muto, Yoshikazu Hayashi, Taiki Abe, Kazuhiko Igarashi, Yoko Aoki

Blood Adv (2023) 7 (18): 5409–5420.

https://doi.org/10.1182/bloodadvances.2022008462

Published: 2023

Includes: Supplemental data

Journal Articles

Addressing fertility in adolescent boys with sickle cell disease: emerging clinical and ethical dilemmas

Leena Nahata, Gwendolyn P. Quinn, John J. Strouse, Susan E. Creary

Blood Adv (2023) 7 (18): 5351–5353.

https://doi.org/10.1182/bloodadvances.2023010292

Published: 2023

Journal Articles

FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years

Shai Shimony, Geoffrey Fell, Evan C. Chen, Harrison K. Tsai, Martha Wadleigh, Eric S. Winer, Jacqueline S. Garcia, Marlise R. Luskin, Maximilian Stahl, Donna S. Neuberg, Daniel J. DeAngelo, R. Coleman Lindsley, Richard M. Stone

Blood Adv (2023) 7 (18): 5354–5358.

https://doi.org/10.1182/bloodadvances.2023009748

Published: 2023

Includes: Supplemental data

Journal Articles

Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E–positive LCH

Blood Adv (2023) 7 (18): 5246–5257.

https://doi.org/10.1182/bloodadvances.2022009067

Published: 2023

Includes: Supplemental data

Journal Articles

An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy

Faheem Farooq, Justin S. Brandt, Elyce Cardonick, Evgeniya Polushkina, Julie Vose, Sairah Ahmed, Praveen Ramakrishnan Geethakumari, Adam J. Olszewski, Hesham Yasin, Umar Farooq, Nada Hamad, Yong Lin, Charlotte Maggen, Robert Fruscio, Mina Mhallem Gziri, Karina Dahl Steffensen, Frédéric Amant, Andrew M. Evens

Blood Adv (2023) 7 (18): 5480–5484.

https://doi.org/10.1182/bloodadvances.2023010090

Published: 2023

Journal Articles

Thromboprophylaxis in hospitalized and nonhospitalized medical patients: what’s new?

Suely M. Rezende, Kenneth A. Bauer, Neil A. Zakai

Blood Adv (2023) 7 (18): 5199–5201.

https://doi.org/10.1182/bloodadvances.2023010067

Published: 2023

Journal Articles

A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America

Juan Rangel-Patiño, Yu Ling Lee-Tsai, Victor Itaí Urbalejo-Ceniceros, Maria Elena Monserrat Luna-Perez, Karla Adriana Espinosa-Bautista, Lauro Fabian Amador, Álvaro Cabrera-García, Carolina Balderas-Delgado, Sergio I Inclan-Alarcon, Yvette Neme-Yunes, Jose Manuel Sanchez-Albarrán, Elia Ixel Apodaca, Luis Meillon-García, Wendy Stock, Roberta Demichelis-Gómez

Blood Adv (2023) 7 (18): 5202–5209.

https://doi.org/10.1182/bloodadvances.2023009754

Published: 2023

Journal Articles

Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens

Sumanth Mosale Seetharam, Yi Liu, Jason Wu, Lenn Fechter, Kanagavel Murugesan, Holden Maecker, Jason Gotlib, James Zehnder, Ramasamy Paulmurugan, Anandi Krishnan

Blood Adv (2023) 7 (18): 5433–5445.

https://doi.org/10.1182/bloodadvances.2022008939

Published: 2023

Includes: Supplemental data

Journal Articles

Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study

Carol Moreno, Isabelle G. Solman, Constantine S. Tam, Andrew Grigg, Lydia Scarfò, Thomas J. Kipps, Srimathi Srinivasan, Raghuveer Singh Mali, Cathy Zhou, James P. Dean, Edith Szafer-Glusman, Michael Choi

Blood Adv (2023) 7 (18): 5294–5303.

https://doi.org/10.1182/bloodadvances.2023010236

Published: 2023

Includes: Supplemental data

Journal Articles

Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor

Zachary D. Crees, Michael P. Rettig, Asad Bashey, Steven M. Devine, Samantha Jaglowski, Fei Wan, Amy Zhou, Melinda Harding, Abi Vainstein-Haras, Ella Sorani, Irit Gliko-Kabir, Brenda J. Grossman, Peter Westervelt, John F. DiPersio, Geoffrey L. Uy

Blood Adv (2023) 7 (18): 5210–5214.

https://doi.org/10.1182/bloodadvances.2023010407

Published: 2023

Includes: Supplemental data

Journal Articles

Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up

Pier Luigi Zinzani, Armando Santoro, Giuseppe Gritti, Pauline Brice, Paul M. Barr, John Kuruvilla, David Cunningham, Justin Kline, Nathalie A. Johnson, Neha Mehta-Shah, Julie Lisano, Rachael Wen, Alev Akyol, Alison J. Moskowitz

Blood Adv (2023) 7 (18): 5272–5280.

https://doi.org/10.1182/bloodadvances.2023010254

Published: 2023

Includes: Supplemental data

Journal Articles

Mesenchymal stromal cells ameliorate chronic GVHD by boosting thymic regeneration in a CCR9-dependent manner in mice

Xin Zhang, Jiabao He, Ke Zhao, Shiqi Liu, Li Xuan, Shan Chen, Rongtao Xue, Ren Lin, Jun Xu, Yan Zhang, Andy Peng Xiang, Hua Jin, Qifa Liu

Blood Adv (2023) 7 (18): 5359–5373.

https://doi.org/10.1182/bloodadvances.2022009646

Published: 2023

Includes: Supplemental data

Journal Articles

Single-cell multiomics of human fetal hematopoiesis define a developmental-specific population and a fetal signature

Mikael N. E. Sommarin, Rasmus Olofzon, Sara Palo, Parashar Dhapola, Shamit Soneji, Göran Karlsson, Charlotta Böiers

Blood Adv (2023) 7 (18): 5325–5340.

https://doi.org/10.1182/bloodadvances.2023009808

Published: 2023

Includes: Supplemental data

Journal Articles

Association between busulfan exposure and survival in patients undergoing a CD34 + selected stem cell transplantation

Blood Adv (2023) 7 (18): 5225–5233.

https://doi.org/10.1182/bloodadvances.2023009708

Published: 2023

Includes: Supplemental data

Journal Articles

Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials

Shai Shimony, Yael Flamand, Yannis K. Valtis, Andrew E. Place, Lewis B. Silverman, Lynda M. Vrooman, Andrew M. Brunner, Stephen E. Sallan, Richard M. Stone, Martha Wadleigh, Donna S. Neuberg, Daniel J. DeAngelo, Marlise R. Luskin

Blood Adv (2023) 7 (18): 5234–5245.

https://doi.org/10.1182/bloodadvances.2023009976

Published: 2023

Includes: Supplemental data

Journal Articles

Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant

Scott R. Solomon, Melhem Solh, Lawrence E. Morris, Jr., H. Kent Holland, Lizamarie Bachier-Rodriguez, Xu Zhang, Caitlin Guzowski, Katelin C Jackson, Stacey Brown, Asad Bashey

Blood Adv (2023) 7 (18): 5215–5224.

https://doi.org/10.1182/bloodadvances.2023010477

Published: 2023

Includes: Supplemental data

NARROW

Hertz L, Flormann D, Birnbaumer L, et al. Evidence of in vivo exogen protein uptake by red blood cells: a putative therapeutic concept. Blood Adv . 2023;7(6):1033-1039.

A timeline of genetic variant enrichment: from multiple myeloma diagnosis to myeloma-associated myeloid malignancy

Human herpesvirus 6–specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients

Intrinsic tumor resistance to CAR T cells is a dynamic transcriptional state that is exploitable with low-dose radiation

Mecom mutation related to radioulnar synostosis with amegakaryocytic thrombocytopenia reduces HSPCs in mice

Addressing fertility in adolescent boys with sickle cell disease: emerging clinical and ethical dilemmas

FLT3-ITD does not predict inferior prognosis in acute myeloid leukemia patients aged ≥60 years

Vemurafenib combined with cladribine and cytarabine results in durable remission of pediatric BRAF V600E–positive LCH

An international real-world analysis of relapsed/refractory lymphoma occurring during pregnancy

Thromboprophylaxis in hospitalized and nonhospitalized medical patients: what’s new?

A modified CALGB 10403 in adolescents and young adults with acute lymphoblastic leukemia in Central America

Enkurin: a novel marker for myeloproliferative neoplasms from platelet, megakaryocyte, and whole blood specimens

Immune restoration with ibrutinib plus venetoclax in first-line chronic lymphocytic leukemia: the phase 2 CAPTIVATE study

Hematopoietic stem cell mobilization for allogeneic stem cell transplantation by motixafortide, a novel CXCR4 inhibitor

Nivolumab combined with brentuximab vedotin for R/R primary mediastinal large B-cell lymphoma: a 3-year follow-up

Mesenchymal stromal cells ameliorate chronic GVHD by boosting thymic regeneration in a CCR9-dependent manner in mice

Single-cell multiomics of human fetal hematopoiesis define a developmental-specific population and a fetal signature

Association between busulfan exposure and survival in patients undergoing a CD34 + selected stem cell transplantation

Effect of BMI on toxicities and survival among adolescents and young adults treated on DFCI Consortium ALL trials

Phase 2 study of PD-1 blockade following autologous transplantation for patients with AML ineligible for allogeneic transplant

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only